FORNEBU,Norway,Feb. 13,2025-- Aker Horizons ASA (OSE:AKH),a developer of green energy and industry,today announced results for the fourth quarter 2024. Aker Horizons\' net capital employed stood at NO
The first optogenetic "Chimeric Rhodopsin" gene therapy tested in humans. RV-001 starting dose was generally well tolerated in this open-label trial.
TOKYO,Feb. 13,2025-- The global energy sector is gearing up for one of the most anticipated events of the year. From February 19 to 21,2025,Ampace and TDK will jointly exhibit at Tokyo Big Sight (Boot
TOKYO,Feb. 13,2025--TOYO Co.,Ltd (Nasdaq: TOYO) ("TOYO" or the "Company"),a solar solution company,today announced its participation in upcoming industry and investment conferences
NEW YORK,Feb. 13,2025-- In an era of rapid digital transformation,global technology intelligence firm ABI Research has released its highly anticipated 66 Must-Know Tech Stats for 2025: Markets on the
VANCOUVER,BC,Feb. 13,2025-- IFS,the leading provider of enterprise cloud and Industrial AI software,announces that WEL Networks,a leading provider of innovative and sustainable energy solutions and el
